These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 3107904
1. Pharmacotherapy for recovery of function after brain injury. Feeney DM, Sutton RL. Crit Rev Neurobiol; 1987; 3(2):135-97. PubMed ID: 3107904 [Abstract] [Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
6. Conceptual and practical issues in the pharmacological treatment of brain injury. Stein DG, Glasier MM, Hoffman SW. J Neural Transplant Plast; 1993 Dec; 4(3):227-37. PubMed ID: 8018754 [Abstract] [Full Text] [Related]
7. Effects of chronic, post-injury Cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury. Riess P, Bareyre FM, Saatman KE, Cheney JA, Lifshitz J, Raghupathi R, Grady MS, Neugebauer E, McIntosh TK. Restor Neurol Neurosci; 2001 Dec; 18(1):1-8. PubMed ID: 11673665 [Abstract] [Full Text] [Related]
8. Pharmacotherapy to enhance arousal: what is known and what is not. Zafonte R, Hammond F, Dennison A, Chew E. Prog Brain Res; 2009 Dec; 177():293-316. PubMed ID: 19818909 [Abstract] [Full Text] [Related]
9. [Pharmacotherapy of the cognitive sequelae secondary to traumatic brain injury]. Riós-Romenets S, Castaño-Monsalve B, Bernabeu-Guitart M. Rev Neurol; 2009 Dec; 45(9):563-70. PubMed ID: 17979087 [Abstract] [Full Text] [Related]
10. Basic and clinical studies of pharmacologic effects on recovery from brain injury. Goldstein LB. J Neural Transplant Plast; 1993 Dec; 4(3):175-92. PubMed ID: 8018750 [Abstract] [Full Text] [Related]
11. Functional recovery with and without training following brain damage in experimental animals: a review. Yu J. Arch Phys Med Rehabil; 1976 Jan; 57(1):38-41. PubMed ID: 813611 [Abstract] [Full Text] [Related]
12. From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options. Pitkänen A, Immonen RJ, Gröhn OH, Kharatishvili I. Epilepsia; 2009 Feb; 50 Suppl 2():21-9. PubMed ID: 19187291 [Abstract] [Full Text] [Related]
13. Magnesium therapy and recovery of function in experimental models of brain injury and neurodegenerative disease. Hoane MR. Clin Calcium; 2004 Aug; 14(8):65-70. PubMed ID: 15577099 [Abstract] [Full Text] [Related]
14. Pharmacotherapy for traumatic brain injury: a review. Raghupathi R, McIntosh TK. Proc West Pharmacol Soc; 1998 Aug; 41():241-6. PubMed ID: 9836300 [Abstract] [Full Text] [Related]
15. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M, Iacopino DG. Brain Res; 2007 Nov 28; 1182():99-105. PubMed ID: 17935704 [Abstract] [Full Text] [Related]
16. Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. He J, Hoffman SW, Stein DG. Restor Neurol Neurosci; 2004 Nov 28; 22(1):19-31. PubMed ID: 15096691 [Abstract] [Full Text] [Related]
17. Recovery after a traumatic brain injury depends on diurnal variations effect of cystatin C. Martinez-Vargas M, Gonzalez-Rivera R, Soto-Nuñez M, Cisneros-Martinez M, Huerta-Saquero A, Morales-Gomez J, Molina-Guarneros J, Navarro L. Neurosci Lett; 2006 May 29; 400(1-2):21-4. PubMed ID: 16519999 [Abstract] [Full Text] [Related]